Therapy News and Research

RSS

Providing antiretroviral treatment to workers of large companies in Africa is feasible

Providing antiretroviral treatment to workers of large companies in Africa is feasible, according to the authors of a Viewpoint in this week's issue of The Lancet.

3 Aug 2006

Stopping antiretroviral therapy in HIV-infected patients could be beneficial

Stopping antiretroviral therapy in HIV-infected patients from time to time could reduce the side effects and costs of the treatment, according to a study in this week's issue of The Lancet.

3 Aug 2006

Highly active antiretroviral therapy for HIV remains successful

A decade after the introduction of highly active antiretroviral therapy (HAART) for HIV infection in Europe and North America, the risk of AIDS and death remains low for those starting treatment.

3 Aug 2006

Patients receiving treatment with radioisotopes may trigger security alarms

Patients receiving treatment with radioisotopes should be warned that they may trigger radiation alarms, say doctors in this week's British Medical Journal.

3 Aug 2006

Structural alterations in breast stromal and epithelial DNA

Researchers have uncovered a pattern of DNA damage in connective tissues in the human breast that could shed light on the early stages of breast cancer.

3 Aug 2006

Better understanding of intravenous immunoglobulin

For years, researchers have struggled to understand how IVIG worked. It's ability to treat autoimmune diseases seemed to bean apparent contradiction.

3 Aug 2006

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain whether or not they are using a common blood thinning therapy, according to a new study.

3 Aug 2006

Bone marrow lesions in the knee may be hereditary

There is a significant genetic component to the occurrence and severity of bone marrow lesions in the tibia and femur.

3 Aug 2006

Smokers who experience significant pain smoke more

Smokers who experience significant pain smoke more cigarettes per day than those who are not regularly in pain, according to a study published by researchers at the University of Kentucky.

3 Aug 2006

Variation in the CHEK2 gene may triple a woman's risk of developing breast cancer

Study shows that women in the general population who carry a specific CHEK2 mutation are three times as likely as women without the mutation to develop breast cancer.

2 Aug 2006

Darunavir - first molecule to treat drug-resistant HIV

Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.

2 Aug 2006

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma

The results of this study appear in the August 2006 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS).

2 Aug 2006

Guidelines on atrial fibrillation recommend new approach

Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation (AF), according to revised Guidelines for the Management of Patients with Atrial Fibrillation.

2 Aug 2006

Likelihood of hemorrhage on warfarin is relatively small

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain whether or not they are using a common blood thinning therapy, according to a new study.

2 Aug 2006

FDA approves Keppra (levetiracetam) for epilepsy treatment

UCB has announced that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) injection for use as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy.

2 Aug 2006

Practical advice and individualized attention can help people with HIV stick to a consistent drug regimen

The studies were too different to combine results, but the review team found that the most successful programs emphasized "practical medicine management," one-on-one attention or a 12-week or longer duration.

2 Aug 2006

Researchers determine why gene therapy treatment caused leukemia in some X-linked severe combined immunodeficiency patients

Scientists at St. Jude Children's Research Hospital have developed a mouse model of a severe disease of the immune system that helps explain why gene therapy used to treat children with this disease at an institution in Europe caused some of them to develop leukemia.

2 Aug 2006